169 related articles for article (PubMed ID: 25584)
1. Immunologic aspects of malignancy.
Pirofsky B
Am J Obstet Gynecol; 1978 May; 131(2):180-5. PubMed ID: 25584
[TBL] [Abstract][Full Text] [Related]
2. An insight into cancer immunology and immunotherapy.
Thompson RB
Prog Clin Pathol; 1975; 6():159-76. PubMed ID: 1105670
[No Abstract] [Full Text] [Related]
3. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
Mathé G
Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
[No Abstract] [Full Text] [Related]
4. [Effect of immune processes on the growth and regression of malignant tumors].
Russo V; Russo L
Vopr Onkol; 1974; 20(6):68-75. PubMed ID: 4603500
[No Abstract] [Full Text] [Related]
5. Harnessing the immunity system: from potential to reality.
Good RA
CA Cancer J Clin; 1975; 25(4):178-86. PubMed ID: 805637
[No Abstract] [Full Text] [Related]
6. [Clinical aspects of immunological phenomena in human neoplasms].
Hancock BW
Recenti Prog Med; 1978 Sep; 65(3):205-16. PubMed ID: 360326
[No Abstract] [Full Text] [Related]
7. [Immunologic aspects of neoplastic disease].
Dawidiuk W; Szczepaniec M
Ginekol Pol; 1979 Jun; 50(6):537-48. PubMed ID: 383581
[No Abstract] [Full Text] [Related]
8. Prospects for the immunotherapy of cancer. Part I: Basic concepts of tumor immunology.
Pilch YH; Myers GH; Sparks FC; Golub SH
Curr Probl Surg; 1975 Jan; ():1-46. PubMed ID: 236150
[No Abstract] [Full Text] [Related]
9. Editorial: Cancer immunotherapy.
Hussey HH
JAMA; 1974 Jan; 227(4):435. PubMed ID: 4543616
[No Abstract] [Full Text] [Related]
10. Immunodeficiency and cancer: mechanisms involved.
Cottier H; Hess MW; Wälti ER
Schweiz Med Wochenschr; 1986 Aug; 116(34):1119-26. PubMed ID: 3532311
[TBL] [Abstract][Full Text] [Related]
11. Loss of suppressor function as a cause of lymphoid malignancy.
Gershwin ME; Steinberg AD
Lancet; 1973 Nov; 2(7839):1174-6. PubMed ID: 4127550
[No Abstract] [Full Text] [Related]
12. Tumor immunology.
McKhann CF; Yarlott MA
CA Cancer J Clin; 1975; 25(4):187-97. PubMed ID: 805638
[No Abstract] [Full Text] [Related]
13. Malignancy as a complication of immunosuppressive therapy.
Leibowitz S; Schwartz RS
Adv Intern Med; 1971; 17():95-123. PubMed ID: 4145004
[No Abstract] [Full Text] [Related]
14. Primary immunodeficiency and malignancy.
Kersey JH; Spector BD; Good RA
Birth Defects Orig Artic Ser; 1975; 11(1):289-98. PubMed ID: 238676
[TBL] [Abstract][Full Text] [Related]
15. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
16. [Problems of tumor immunology and immunotherapy].
Schmidt CG
Helv Chir Acta; 1973 Mar; 40(1):77-86. PubMed ID: 4540691
[No Abstract] [Full Text] [Related]
17. The suppressor-cell network in cancer (second of two parts).
Broder S; Waldmann TA
N Engl J Med; 1978 Dec; 299(24):1335-41. PubMed ID: 362202
[No Abstract] [Full Text] [Related]
18. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
Jäger D; Jäger E; Bert F; Knuth A
Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
[No Abstract] [Full Text] [Related]
19. Immunologic aspects of malignant tumors.
Ariyan S
Clin Plast Surg; 1979 Apr; 6(2):125-142. PubMed ID: 313868
[No Abstract] [Full Text] [Related]
20. Current trends in basic immunology as applied to the problem of human neoplasia.
Dmochowski L; Bowen JM
Am J Clin Pathol; 1974 Aug; 62(2):167-72. PubMed ID: 4602085
[No Abstract] [Full Text] [Related]
[Next] [New Search]
